National Cancer Institute selects Apexian Pharmaceuticals to participate in the Small Business Innovation Research (SBIR) Initiative program
September 27, 2017 10:00 ET
|
Apexian Pharmaceuticals
Indianapolis, Indiana, USA, Sept. 27, 2017 (GLOBE NEWSWIRE) --...
Apexian Pharmaceuticals Announces FDA Agreement For Inclusion of Chemotherapy Induced Peripheral Neuropathy (CIPN) Indication Under Currently Approved IND
July 13, 2017 08:00 ET
|
Apexian Pharmaceuticals
INDIANAPOLIS, IN --(Marketwired - July 13, 2017) - Apexian Pharmaceuticals, a clinical stage biotechnology company developing novel compounds to treat cancer, today announced that it has received FDA...
Early-stage clinical oncology company, Apexian Pharmaceuticals, licenses IU discoveries
June 05, 2017 10:00 ET
|
Apexian Pharmaceuticals
INDIANAPOLIS, IN--(Marketwired - June 05, 2017) - Apexian Pharmaceuticals Inc., a biotechnology company focused on developing novel compounds to treat cancer, has licensed all technology discovered...
Apexian Pharmaceuticals Announces FDA Acceptance of Phase 1 Protocol to Include Biomarker Measurements and Evaluate the Tolerability and Anti-Tumor Effects of APX3330
March 01, 2017 15:21 ET
|
Apexian Pharmaceuticals
INDIANAPOLIS, IN--(Marketwired - March 01, 2017) - Apexian Pharmaceuticals, a clinical stage biotechnology company developing novel compounds to treat cancer, today announced that it has received FDA...
Apexian Pharmaceutical CEO, Steve Carchedi, to present at Drexel University's Guest Healthcare Lecture Series
February 22, 2017 08:04 ET
|
Apexian Pharmaceuticals
PHILADELPHIA, PA--(Marketwired - February 22, 2017) - Apexian Pharmaceuticals, a clinical stage biotechnology company focused on developing novel compounds to treat cancer, today announced that its...
Apexian Pharmaceutical CEO, Steve Carchedi, to present at BIO CEO and Investor Conference
February 03, 2017 16:28 ET
|
Apexian Pharmaceuticals
INDIANAPOLIS, IN--(Marketwired - February 03, 2017) - Apexian Pharmaceuticals, a clinical stage biotechnology company focused on developing novel compounds to treat cancer, today announced that its...
Apexian Pharmaceuticals Hires Richard Messmann, M.D. as Chief Medical Officer
October 31, 2016 08:00 ET
|
Apexian Pharmaceutical, Inc
INDIANAPOLIS, IN--(Marketwired - October 31, 2016) - Apexian Pharmaceutical, Inc., a clinical stage biotechnology company focused on developing novel compounds to treat cancer, today announced the...
ApeX Therapeutics Changes Name to Apexian Pharmaceuticals to Reflect Broader Advancement of Oncology Pipeline
October 24, 2016 08:00 ET
|
Apexian Pharmaceuticals, Inc.
INDIANAPOLIS, IN--(Marketwired - October 24, 2016) - ApeX Therapeutics, a clinical stage biotechnology company focused on developing novel compounds to treat cancer, today announced that it has...
ApeX Therapeutics Appoints Industry Veteran Steve Carchedi as CEO and Director
October 10, 2016 08:00 ET
|
ApeX Therapeutics, Inc.
INDIANAPOLIS, IN--(Marketwired - October 10, 2016) - ApeX Therapeutics, a clinical stage biotechnology company focused on developing novel compounds to treat cancer, today announced the appointment of...
ApeX Therapeutics Announces FDA Acceptance of IND to Evaluate the Tolerability and Anti-Tumor Effects of APX3330
July 20, 2016 08:00 ET
|
ApeX Therapeutics, Inc.
INDIANAPOLIS, IN--(Marketwired - July 20, 2016) - ApeX Therapeutics, a biotechnology company focused on developing novel compounds to treat cancer, today announced the acceptance of an Investigational...